Literature DB >> 27065576

Evaluation of ETV6/RUNX1 Fusion and Additional Abnormalities Involving ETV6 and/or RUNX1 Genes Using FISH Technique in Patients with Childhood Acute Lymphoblastic Leukemia.

Cigdem Aydin1, Zafer Cetin2, Ayse Esra Manguoglu3, Funda Tayfun4, Ozden Altiok Clark5, Alphan Kupesiz4, Bahar Akkaya6, Sibel Berker Karauzum3.   

Abstract

Childhood acute lymphoblastic leukemia (ALL) is the most common type of childhood leukemia. Specifically, ALL is a malignant disorder of the lymphoid progenitor cells, with a peak incidence among children aged 2-5 years. The t(12;21)(p13;q22) translocation occurs in 25 % of childhood B cell precursor ALL. In this study, bone marrow samples were obtained from 165 patients with childhood ALL. We analyzed the t(12;21) translocation and other related abnormalities using the fluorescent in situ hybridization (FISH) technique with the ETV6(TEL)/RUNX1(AML1) ES dual color translocation probe. Conventional cytogenetic analyses were also performed. ETV6 and RUNX1 related chromosomal abnormalities were found in 42 (25.5 %) of the 165 patients with childhood ALL. Among these 42 patients, structural changes were detected in 33 (78.6 %) and numerical abnormalities in 9 (21.4 %). The frequency of FISH abnormalities in pediatric ALL cases were as follows: 8.5 % for t(12;21)(p13;q22) ETV6/RUNX1 fusion, 6.0 % for RUNX1 amplification, 3.0 % for tetrasomy/trisomy 21, 1.8 % for ETV6 deletion, 1.21 % for ETV6 deletion with RUNX1 amplification, 1.21 % for ETV6 amplification with RUNX1 amplification, 0.6 % for polyploidy, 0.6 % for RUNX1 deletion, and 0.6 % for diminished ETV6 signal. The most common structural abnormality was the t(12;21) translocation, followed by RUNX1 amplification and ETV6 deletion, while the most commonly observed numerical abnormality was trisomy 21.

Entities:  

Keywords:  Acute lymphoblastic leukemia; ETV6; FISH; RUNX1; t(12;21) translocation

Year:  2015        PMID: 27065576      PMCID: PMC4789003          DOI: 10.1007/s12288-015-0557-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  30 in total

1.  The presence of TEL/AML1 rearrangement and cryptic deletion of the TEL gene in adult acute lymphoblastic leukemia (ALL).

Authors:  Dong Soon Lee; Young Ree Kim; Hyung Kyun Cho; Chung Kee Lee; Jee Hyung Lee; Han Ik Cho
Journal:  Cancer Genet Cytogenet       Date:  2005-10-15

Review 2.  The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia.

Authors:  C J Harrison
Journal:  Blood Rev       Date:  2001-03       Impact factor: 8.250

Review 3.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Authors:  J J van Dongen; E A Macintyre; J A Gabert; E Delabesse; V Rossi; G Saglio; E Gottardi; A Rambaldi; G Dotti; F Griesinger; A Parreira; P Gameiro; M G Diáz; M Malec; A W Langerak; J F San Miguel; A Biondi
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

4.  High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.

Authors:  D C Liang; T B Chou; J S Chen; S A Shurtleff; J E Rubnitz; J R Downing; C H Pui; L Y Shih
Journal:  Leukemia       Date:  1996-06       Impact factor: 11.528

5.  Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India.

Authors:  N Inamdar; S A Kumar; S D Banavali; S Advani; I Magrath; K Bhatia
Journal:  Int J Oncol       Date:  1998-12       Impact factor: 5.650

6.  High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukemia and known clinical outcome in southern Brazil.

Authors:  Loraine Beatriz Acosta Veiga; Virginia Maria Cóser; Luciane Regina Cavalli; Iglenir João Cavalli; Jacqueline Nunes Rodrigues; Waldir Veiga Pereira; Dalnei Veiga Pereira; Thereza Christina Sampaio Lafayette; Benônio Terra Villalba; Mauber Eduardo Schultz Moreira; Bassem R Haddad; Enilze Maria de Souza Fonseca Ribeiro
Journal:  Leuk Res       Date:  2004-10       Impact factor: 3.156

7.  Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21).

Authors:  S P Romana; M Le Coniat; H Poirel; P Marynen; O Bernard; R Berger
Journal:  Leukemia       Date:  1996-01       Impact factor: 11.528

8.  TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

Authors:  S A Shurtleff; A Buijs; F G Behm; J E Rubnitz; S C Raimondi; M L Hancock; G C Chan; C H Pui; G Grosveld; J R Downing
Journal:  Leukemia       Date:  1995-12       Impact factor: 11.528

9.  t(12;21): a new recurrent translocation in acute lymphoblastic leukemia.

Authors:  S P Romana; M Le Coniat; R Berger
Journal:  Genes Chromosomes Cancer       Date:  1994-03       Impact factor: 5.006

10.  The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.

Authors:  S P Romana; M Mauchauffé; M Le Coniat; I Chumakov; D Le Paslier; R Berger; O A Bernard
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  3 in total

1.  Old and New Prognostic Markers in Pediatric ALL.

Authors:  Hara Prasad Pati; Prashant Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-23       Impact factor: 0.900

2.  Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia.

Authors:  JinFang Zhang; LingJi Zeng; YuLian Wang; JianWei Pan; XingDong Li; Bei Feng; Quan Yang
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

3.  Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children's Leukemia Group.

Authors:  Kun-Yin Qiu; Hong-Gui Xu; Xue-Qun Luo; Hui-Rong Mai; Ning Liao; Li-Hua Yang; Min-Cui Zheng; Wu-Qing Wan; Xue-Dong Wu; Ri-Yang Liu; Qi-Wen Chen; Hui-Qin Chen; Xiao-Fei Sun; Hua Jiang; Xing-Jiang Long; Guo-Hua Chen; Xin-Yu Li; Chang-Gang Li; Li-Bin Huang; Ya-Yun Ling; Dan-Na Lin; Chuan Wen; Wen-Yong Kuang; Xiao-Qin Feng; Zhong-Lv Ye; Bei-Yan Wu; Xiang-Lin He; Qiao-Ru Li; Li-Na Wang; Xian-Ling Kong; Lu-Hong Xu; Chi-Kong Li; Jian-Pei Fang
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.